Featured Editorial

  1. Emerging RNA Delivery Strategies For Solid Tumor Oncology 11/20/2025

    RNA shows promise in solid tumors, but delivery remains the core challenge. New targeting and delivery strategies aim to overcome tumor barriers and unlock RNA’s full therapeutic potential.

  2. Trends In Oligo Scale-Up & Delivery & How They're Impacting Manufacturing 11/14/2025

    Here, a panel of experts at the RNA Leaders Conference gives a fantastic overview of where we are today and why, as one expert so nicely put it, “This is one of the most fun times to be an oligo scientist or chemist.” 

  3. Innovation, Growth (and Happiness) Projected for Pharma 11/10/2025

    Not only is investment increasing in pharma, but innovation is propelling growth in multiple drug segments, and the people supporting this growth and innovation remain happy.

  4. The 9 Fastest-Growing Outsourcing Segments 11/7/2025

    Capacity isn’t the choke point—capability is; this piece ranks nine fast-growing outsourcing segments and shows sponsors how to win by locking in modality-proven partners early.

  5. Inside NeoVac's LNP Formulation Strategy: Challenges, Innovation, And What Comes Next 11/6/2025

    NeoVac CEO Jan Egberts, MD, discusses the science, regulation, and innovation shaping next-gen LNPs—and why true progress in mRNA therapeutics may depend more on understanding than on AI.

  6. Overcoming CMC Challenges In The Development Of Conjugated LNP Platforms For In Vivo CAR-T Therapy 11/4/2025

    Overcoming CMC hurdles is key to advancing conjugated LNP platforms for in vivo CAR-T therapy, enabling scalable, precise mRNA delivery to T cells while maintaining stability, potency, and regulatory compliance.

  7. Makary Talks Faster Drug Reviews, 'Continuous Trials,' DTC Ads 11/3/2025

    Part one of a two-part series on FDA Commissioner Martin Makary, M.D.'s comments at the Gailen Forum in New York City on October 30, 2025.

  8. Beyond the Hype: Industry Experts on the Reality of mRNA in Cancer Care 10/31/2025

    When I asked a panel of experts at RNA Leaders why mRNA was best positioned to shine in oncology, I was met with a few expected talking points and — better yet — a few I wasn’t expecting. 

  9. Tackling Challenges In RNA Stability And Organ Targeting 10/28/2025

    RNA therapeutics are reshaping medicine, but instability and limited organ targeting still pose challenges. Discover how next-gen lipid nanoparticles and smart delivery systems are advancing RNA precision.

  10. Developing Exosome-Based RNA Therapeutics For CNS Regeneration 10/24/2025

    Inside the effort to use exosomes as natural nanocarriers that deliver RNA therapeutics safely across the blood–brain barrier to heal damaged neural tissue.